Discover March 2025’s top biotech deals, featuring major collaborations in small molecules, bispecific antibodies and protein ...

MEPPI will construct a new approximately 160,000 square foot Advanced Switchgear Factory in Western Pennsylvania, marking ...

Cambridge-headquartered AstraZeneca is investing $2.5 billion in Beijing to establish its sixth global strategic R & D centre ...

Montgomery County officials launched Mobilize Montgomery, a public-private partnership aimed at supporting businesses and ...

HONG KONG, LONDON] Ever since AstraZeneca shocked investors in October with news its China chief was under investigation, the ...

The team from Massachusetts Institute of Technology (MIT) have suggested that the technology could be useful for applications ...

Discover the top gainers and losers in the S&P 500 Healthcare Index and stay updated on major news like J&J's $55B investment and Pfizer's Haleon stake exit.

AstraZeneca is making a major push into cell therapy with the acquisition of EsoBiotec, a company that has developed a ...

FEMA’s acting administrator says his own parents have received a letter denying hurricane recovery aid — with his name on it.

AstraZeneca has entered into a definitive agreement to acquire EsoBiotec, a biotechnology company pioneering in vivo cell ...

While the allogeneic vs autologous debate continues in the cell therapy field, research on in vivo therapies is drawing interest.

In this week’s edition of InnovationRx, we look at the policy uncertainty around vaccines, sex differences in GLP-1 drug side effects, the challenges of using AI to predict epidemics and more.